Incyte Claims Sun Pharma's Alopecia Drug Launch Violates IP

By Hanna Vioque ( October 21, 2025, 7:58 PM BST) -- Incyte has fought back against the Indian pharmaceutical company Sun Pharma's bid to nix three patents protecting a blockbuster drug treating autoimmune conditions, arguing that once it launches in 2026, Sun Pharma's treatment for hair loss will infringe Incyte's intellectual property. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login